Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NICO has developed the first FDA-cleared minimally invasive device platform for accessing and removing deep-seated brain pathologies. In a pivotal trial for hemorrhagic stroke, patients treated with the device had a 98.1% probability of superior functional outcomes compared to medical management alone. The company’s technology also enables high-quality tissue preservation for advanced molecular analysis in neuro-oncology research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nico Galleria.